| Bioactivity | BTK-IN-31 (Compound 2) is a selective, non-covalently reversible, and blood-brain barrier (BBB) permeable Btk inhibitor. BTK-IN-31 has research potential in immune disorders, cancer, cardiovascular disease, viral infections, inflammation, metabolic/endocrine dysfunction, and neurological disorders[1]. |
| Name | BTK-IN-31 |
| CAS | 2662512-02-7 |
| Formula | C24H23FN4O3 |
| Molar Mass | 434.46 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Quan Zhou, et al. Btk inhibitors. Patent WO2021136219A1. |
BTK-IN-31
CAS: 2662512-02-7 F: C24H23FN4O3 W: 434.46
BTK-IN-31 (Compound 2) is a selective, non-covalently reversible, and blood-brain barrier (BBB) permeable Btk inhibitor.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.